Corindus IPO (May 29, 2015)
Renaissance Capital IPO Center: Corindus Vascular Robotics, which sells robotic systems that aid stent placement during coronary angioplasties, raised $42 million on Thursday night by offering 11 million shares at $3.80.
The company’s stock had been trading on the OTCQB under the symbol CVRS at $4.25 when Corindus set terms on Tuesday for the public offering. Its shares had fallen to $4.00 on Friday on low volume.
Primary shareholders include HealthCor Partners Management (38% post-IPO stake), Koninklijke Philips (18%), Robert Smith (9%), 20/20 Capital (6%) and CEO David Handler (3%).
Corindus Vascular Robotics listed its shares on the NYSE MKT under the symbol CVRS. Cowen & Company and Stifel acted as lead managers on the deal.
Renaissance Capital IPO Center: Corindus Vascular Robotics (NYSE: CVRS)
Previous private placement (September 19, 2014)
Previously, Corindus has raised (September 2014) approximately $26.6 million through a Securities Purchase Agreement pursuant.
Corindus will issue and sell to certain accredited investors an aggregate of 10,666,570 shares of its common stock in a private placement at a purchase price of $2.50 per share, resulting in aggregate gross proceeds of approximately $26.6 million.